- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Services
- Sub-Industry: Medical Labs&Testing Srv
Quest Diagnostics Inc
+ Add to WatchlistDGX:US
60.6900 USD 0.8100 1.35%As of 20:04:03 ET on 05/17/2013.
Snapshot for Quest Diagnostics Inc (DGX)
| Open: | 59.8600 | Day's Range: | 59.7900 - 60.7900 | Volume: | 972,471 |
|---|---|---|---|---|---|
| Previous Close: | 59.8800 | 52wk Range: | 53.2500 - 64.8700 | 1-Yr Rtn: | +9.37% |
Key Statistics for DGX
| Current P/E Ratio (ttm) | 14.2842 |
|---|---|
| Estimated P/E(12/2013) | 13.8467 |
| Relative P/E vs. SPX | 0.8755 |
| Earnings Per Share (USD) (ttm) | 4.2487 |
| Est. EPS (USD) (12/2013) | 4.3830 |
| Est. PEG Ratio | 1.2733 |
| Market Cap (M USD) | 9,590.80 |
| Shares Outstanding (M) | 158.03 |
| 30 Day Average Volume | 1,540,872 |
| Price/Book (mrq) | 2.2818 |
| Price/Sale (ttm) | 1.3145 |
| Dividend Indicated Gross Yield | 1.98% |
| Cash Dividend (USD) | 0.3000 |
| Last Dividend | 03/28/2013 |
| 5 Year Dividend Growth | 18.64% |
| Next Earnings Announcement | 07/19/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for DGX
Company Profile & Key Executives for DGX
Quest Diagnostics Incorporated provides diagnostic testing, information, and services. The Company operates a national network of full-service laboratories, rapid response laboratories, and patient service centers. Quest Diagnostics provides esoteric testing, routine medical testing, drugs of abuse testing, and non-hospital-based anatomicpathology testing.
| Stephen H Rusckowski "Steve"President/CEO | Robert A Hagemann "Bob"Senior VP/CFO |
| Jon R CohenSenior VP/Chief Medical Ofcr | Michael E PrevoznikSenior VP/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
DGX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page